- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Soluble recombinant human fibroblast growth factor receptor
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Soluble recombinant human fibroblast growth factor receptor 3
| EU orphan designation number: | EU/3/17/1843
|
| Active ingredient: | Soluble recombinant human fibroblast growth factor receptor 3 |
| Indication: | Treatment of achondroplasia |
| Sponsor: | TherAchon SAS
2000 Route des Lucioles, Les Algorithmes - Aristote A, 06410 Biot, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/03/2017 | Orphan designation | EMA/OD/269/16 | (2017)1509 of 27/02/2017 |
CONTACT
EU links
Directorate General Health & Consumers